All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.

The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What baseline factors affect QoL in MDS? How do these change with treatment?

Jun 18, 2021
Share:

During the 2021 ASCO Annual Meeting, the MDS Hub spoke with Mikkael A. Sekeres, Sylvester Comprehensive Cancer Center, Miami, US. We asked, What baseline factors affect quality of life (QoL) in MDS? How do these change with treatment?

What baseline factors affect QoL in MDS? How do these change with treatment?

Sekeres firstly defines QoL assessment in MDS, and highlights the effect of cytopenia. He also discusses the challenges of measuring changes in QoL with treatment, particularly for randomized trials. Finally, he proposes improvements to QoL assessment, focusing on wearables that measure activity.

Share:
More about...